CVR: 43055909
Ousia Pharma ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2022. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Christoffer Clemmensen, Jonas Odgaard Petersen and Anders Bue Klein. The company's owners include BII Holdings A/S, Science Studio Holding ApS and Nordic Alchemy Holding ApS. In 2025, the company reported a gross profit of DKK -10,204,929 and a net result of DKK -12,777,761 compared with DKK -5,348,579 the year before. Equity amounted to DKK 11,818,220.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileFormål er at udvikle nye lægemiddelkandidater til behandling af kroniske sygdomme.
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringCompared to 1.052 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Ousia Pharma ApS has published its annual report for 2025. Gross profit came to DKK -10,204,929, and the net result was DKK -12,777,761.
Ousia Pharma ApS has published its annual report for 2024. Gross profit came to DKK -3,655,869, and the net result was DKK -5,348,579.
As of June 11, 2025, BII Holdings A/S is registered as an owner of Ousia Pharma ApS with an ownership share of 10%.
As of March 27, 2025, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Ousia Pharma ApS.
As of March 27, 2025, Menelas Nicolas Pangalos has joined the board of directors of Ousia Pharma ApS.
As of March 27, 2025, Otello Stampacchia has joined the board of directors of Ousia Pharma ApS.
As of March 27, 2025, Margareta Elisabeth Björk has joined the board of directors of Ousia Pharma ApS.
As of March 27, 2025, Mikael Søndergaard Thomsen has left the board of directors of Ousia Pharma ApS.
As of March 27, 2025, Jeppe Ragnar Andersen has left the board of directors of Ousia Pharma ApS.
As of March 27, 2025, Morten Peltola Toft has left the board of directors of Ousia Pharma ApS.
As of March 27, 2025, Jonas Odgaard Petersen has left the board of directors of Ousia Pharma ApS.
As of March 27, 2025, Anders Bue Klein has left the board of directors of Ousia Pharma ApS.
As of March 27, 2025, Science Studio Holding ApS is registered as an owner of Ousia Pharma ApS with an ownership share of 15%.
As of March 27, 2025, Nordic Alchemy Holding ApS is registered as an owner of Ousia Pharma ApS with an ownership share of 15%.
As of March 27, 2025, Klein Science Holding ApS is registered as an owner of Ousia Pharma ApS with an ownership share of 15%.
As of March 27, 2025, is registered as an owner of Ousia Pharma ApS with an ownership share of 15%.
Ousia Pharma ApS has published its annual report for 2023. Gross profit came to DKK -2,239,754, and the net result was DKK -3,746,803.
Ousia Pharma ApS has published its interim report for the period February 14, 2022 – December 31, 2022.
As of February 14, 2023, Ian Rodney Laquian has joined the board of directors of Ousia Pharma ApS.
As of February 14, 2023, Mikael Søndergaard Thomsen has joined the board of directors of Ousia Pharma ApS.
As of February 14, 2023, Jeppe Ragnar Andersen has joined the board of directors of Ousia Pharma ApS.
As of February 14, 2023, Morten Peltola Toft has joined the board of directors of Ousia Pharma ApS.
As of February 14, 2023, Christoffer Clemmensen has joined the board of directors of Ousia Pharma ApS.
As of February 14, 2023, Jonas Odgaard Petersen has joined the board of directors of Ousia Pharma ApS.
As of February 14, 2023, Anders Bue Klein has joined the board of directors of Ousia Pharma ApS.
As of February 14, 2022, Christoffer Clemmensen is registered as director of Ousia Pharma ApS.
As of February 14, 2022, Jonas Odgaard Petersen is registered as director of Ousia Pharma ApS.
As of February 14, 2022, Anders Bue Klein is registered as director of Ousia Pharma ApS.
Ousia Pharma ApS was founded on February 14, 2022.
Companies in the same industry and area
CVR 45436497
CVR 46543912
CVR 40766383
CVR 42731323
CVR 38599119
companydata.dk